Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

All Conditions

Infections

Symptoms and General Pathology

Uterine Cervical Neoplasms

Communicable Diseases

Papillomavirus Infections

Uterine Cervical Diseases

Papilloma

Virus Diseases

Uterine Diseases

DNA Virus Infections

Tumor Virus Infections

Uterine Neoplasms

Genital Neoplasms, Female

Urogenital Neoplasms

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Sexually Transmitted Diseases

Sexually Transmitted Diseases, Viral

Disease Attributes

At the three intervention clinics, clinic providers or staff will offer women the option to perform HPV self-sampling as an alternative to cervical cancer screening by a clinician.

Control clinics will have passive participation and their only involvement will be that data will be pulled from these clinics. Women in the control clinics will be offered usual care cervical cancer screening by a clinician. The research team will not have any contact with women in the control clinics.

The study will implement HPV self-sampling as an option for cervical cancer screening alongside usual care for Somali women, and evaluate changes pre and post implementation, compared to Fairview intervention clinics.

COPAN 552c.80 FLOQSwab

Christina Bliss Barsness

Rebekah Pratt, MD

This study plans to assess the effect of implementing HPV self-sampling in primary care on uptake of cervical cancer screening in 30-65 year old Somali women who are due for cervical cancer screening.

Hybrid Type 2 effectiveness-implementation study; difference-in-difference methods to compare between-period changes in 3 intervention and Fairview non-intervention clinics.

HPV Self-Sampling in Somali Women

Reducing Cervical Cancer Screening Disparities in Somali Immigrant Women Through a Primary Case-based HPV Self-sampling Intervention

Our operational definition of screening uptake accounts for hybrid options that allow for either HPV self-sampling, or Pap and/or HPV testing by a clinician. We define screening uptake as follows: a) receiving Pap and/or HPV testing by a clinician; b) completing a self-sampling kit that is negative for all HPV or is HPV16/18+; or c) completing a self-sampling kit that is negative for HPV16/18 but positive for other types (i.e., "HPV+ other") or unsatisfactory.

University of Minnesota

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
HPV Self-Sampling in Somali Women	NCT05453006	Cervical Cancer Papillomavirus ... Uterine Disease... Uterine Cervica...	COPAN 552c.80 F...	30 Years - 65 Years	University of Minnesota
HPV Self-Sampling in Somali Women	NCT05453006	Cervical Cancer Papillomavirus ... Uterine Disease... Uterine Cervica...	COPAN 552c.80 F...	30 Years - 65 Years	University of Minnesota

Spots Global Cancer Trial Database for copan 552c.80 floqswab